Matthaei, et al.. Randomized, Double-blind Trial of Triple Therapy with Saxagliptin Add-on to Dapagliflozin Plus Metformin in Patients with Type 2 Diabetes. no. 11, American Diabetes Association, Aug. 2015, doi:10.2337/dc15-0811.